Fresenius Medical Care AG Stock

Equities

FME

DE0005785802

Healthcare Facilities & Services

Market Closed - Xetra 11:35:09 2024-06-12 EDT 5-day change 1st Jan Change
40.05 EUR +2.38% Intraday chart for Fresenius Medical Care AG +2.32% +5.51%

Financials

Sales 2024 * 19.56B 21.15B 29.03B Sales 2025 * 20.3B 21.95B 30.12B Capitalization 11.48B 12.41B 17.03B
Net income 2024 * 665M 719M 987M Net income 2025 * 964M 1.04B 1.43B EV / Sales 2024 * 1.09 x
Net Debt 2024 * 9.86B 10.66B 14.63B Net Debt 2025 * 8.99B 9.72B 13.34B EV / Sales 2025 * 1.01 x
P/E ratio 2024 *
17.7 x
P/E ratio 2025 *
12.2 x
Employees 117,128
Yield 2024 *
2.64%
Yield 2025 *
3.27%
Free-Float 67.83%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.38%
1 week+2.32%
Current month+2.22%
1 month-0.87%
3 months+8.24%
6 months+4.27%
Current year+5.51%
More quotes
1 week
38.97
Extreme 38.97
40.05
1 month
37.91
Extreme 37.91
42.12
Current year
33.88
Extreme 33.88
42.12
1 year
30.16
Extreme 30.16
49.62
3 years
25.95
Extreme 25.95
71.14
5 years
25.95
Extreme 25.95
81.10
10 years
25.95
Extreme 25.95
93.82
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 19-10-31
Director of Finance/CFO 47 23-09-30
Chief Tech/Sci/R&D Officer 65 08-12-31
Members of the board TitleAgeSince
Director/Board Member 57 16-05-11
Director/Board Member 50 23-07-13
Director/Board Member 56 23-07-13
More insiders
Date Price Change Volume
24-06-12 40.05 +2.38% 412,275
24-06-11 39.12 -0.58% 319,697
24-06-10 39.35 -1.01% 319,741
24-06-07 39.75 +0.91% 367,307
24-06-06 39.39 +0.56% 232,924

Delayed Quote Xetra, June 12, 2024 at 11:35 am

More quotes
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
40.05 EUR
Average target price
39.97 EUR
Spread / Average Target
-0.19%
Consensus